MARNETEGRAGENE AUTOTEMCEL

UNII:	RD86XHH46N
Formula:
Preferred Substance Name:	MARNETEGRAGENE AUTOTEMCEL
GSRS Full Record:	RD86XHH46N i

LADICELL
MARNETEGRAGENE AUTOTEMCEL [INN]
MARNETEGRAGENE AUTOTEMCEL [USAN]
RP-L201
RP-L201 (CELL THERAPY PRODUCT WHICH CONSISTS OF AUTOLOGOUS GENETICALLY MODIFIED CD34+ HEMATOPOIETIC CELLS WHICH ARE TRANSDUCED WITH A LENTIVIRAL VECTOR (LV) (CHIM-CD18-WPRE LV) THAT ENCODES FOR THE CD18 .BETA.-SUBUNIT OF HUMAN .BETA.2 INTEGRINS (ITGB2 GENE PRODUCT))

Inxight Drugs
i
ITIS
i
NCBI Taxonomy
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MARNETEGRAGENE AUTOTEMCEL

Synonyms and Mappings

Resources